Nana Gletsu-Miller, Meredith L Wilcox, Lisa A Spence, Amy J Wright, Liana L Guarneiri, Muhammad M Nadeem, Mark J Hutter, Karen L Sprague, Andrew W Brown, Allon N Friedman, Carol F Kirkpatrick, Kevin C Maki

The purpose of this randomized, double-blind, free-living, controlled feeding, crossover study in adults with increased cardiometabolic risk was to assess the effects of replacing energy from solid fats and added sugars with equivalent energy from one avocado daily on cardiometabolic risk factors.

Ross D Peterson, Liana L Guarneiri, Caryn G Adams, Meredith L Wilcox, Anthony J Clark, Nathan P Rudemiller, Kevin C Maki,  Carrie-Anne Malinczak

Recombinant human lactoferrin (rhLF) is of commercial interest for immune support as a food ingredient. The objective was to evaluate the immunogenicity/alloimmunization potential of Helaina rhLF (effera™) from K. phaffii over a 28-day period compared to bovine LF (bLF). Study 1 was a randomized, double-blind, parallel arm, controlled trial where 66 healthy adults were randomly allocated to 1 of 3 groups: high-dose rhLF (3.4 g/d), low-dose rhLF (0.34 g/d), or bLF (3.4 g/d). Participants completed a 28-day supplementation period with follow-up visits on Days 28, 56, and 84. Study 2 was a 12-week observational study with no intervention that enrolled 24 healthy adults.

Liana L Guarneiri, Meredith L Wilcox, Kevin C Maki

This randomized, double-blind, crossover study evaluated the bioavailability of eicosapentaenoic and docosahexaenoic acids (EPA+DHA) in a phospholipid-enhanced fish oil (PEFO) product versus a krill oil (KO) product (337 versus 206 mg EPA+DHA/1 g capsule) in healthy adults (N = 24). The aim of this study was to assess the plasma levels of EPA, DHA, and EPA+DHA following a single capsule of PEFO versus KO products in healthy adult men and women.

Liana L Guarneiri, Meredith L Wilcox, Chen-Meng Kuan, Kevin C Maki

The purpose of this study was to assess the impact of bitter melon extract supplementation on glycemia in individuals with prediabetes.